Networking E. coli

The paper: G. Butland et al., "Interaction network containing conserved and essential protein complexes in Escherichia coli,' Nature, 433:531-7, 2005. (Cited in 91 papers) The finding: Jack Greenblatt and Andrew Emili from the University of Toronto led a team of Canadian researchers that produced a large-scale map of a bacterial interaction network by tagging and purifying protein complexes from 23% of the Escherichia coli genome.

Written byDavid Secko
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The paper:

G. Butland et al., "Interaction network containing conserved and essential protein complexes in Escherichia coli,' Nature, 433:531-7, 2005. (Cited in 91 papers)

The finding:

Jack Greenblatt and Andrew Emili from the University of Toronto led a team of Canadian researchers that produced a large-scale map of a bacterial interaction network by tagging and purifying protein complexes from 23% of the Escherichia coli genome.

The wrinkle:

Greenblatt's and Emili's group was one of the first to move away from studying binary protein interactions in prokaryotes to examining multiprotein complexes on a genome scale, says Russell Finley Jr., from Wayne State University. "Not only that, they importantly did validation analysis on the complexes to show that the information will be useful to biologists," says Finley, who studies protein interaction networks in Drosophila.

The challenge:

While Greenblatt's and Emili's group has gone on to do similar work in yeast, a hurdle ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies